Kinsella J P, McCurnin D C, Clark R H, Lally K P, Null D M
Department of Pediatrics, Wilford Hall, USAF Medical Center, San Antonio, TX.
J Pediatr Surg. 1992 Jan;27(1):44-7. doi: 10.1016/0022-3468(92)90102-d.
Twenty-one neonates with severe respiratory failure, who met criteria in this center for extracorporeal membrane oxygenation (ECMO), underwent echocardiographic examinations to assess the role of cardiac dysfunction in determining the need for ECMO. The echocardiographic indexes of function included peak aortic and pulmonary flow velocity, aortic and pulmonary acceleration, shortening fraction, velocity of circumferential fiber shortening, right ventricular output, and left ventricular output. Patients were offered a staged treatment protocol using high-frequency oscillatory ventilation (HFOV), followed by ECMO if failing HFOV rescue. Nine patients demonstrated progressive deterioration and required ECMO (group 1); 12 patients recovered without ECMO (group 2). There were no significant intergroup differences in AaDO2, age, weight, gestational age, inotropic support, mean airway pressure, systemic blood pressure, or arterial blood gas parameters. Group 1 had significantly lower pulmonary and aortic peak flow velocities, lower pulmonary acceleration, lower shortening fraction, and lower velocity of circumferential fiber shortening (P less than .05). We found that values for peak pulmonary velocity less than 0.70 m/s with pulmonary acceleration less than 14 m/s2 would predict the need for ECMO in 7 of 9 group 1 patients and recovery without ECMO in 11 of 12 group 2 patients (P less than .01, Fisher's Exact test). We conclude that on initial echocardiographic evaluation, cardiac performance was impaired in those patients who subsequently required ECMO compared with a group of patients with similar severity in gas exchange who recovered without ECMO. We speculate that echocardiographic assessment of cardiac performance in ECMO candidates may prove useful in prediction of the subsequent need for ECMO or expedient transfer to an ECMO center.
21名患有严重呼吸衰竭且符合本中心体外膜肺氧合(ECMO)标准的新生儿接受了超声心动图检查,以评估心脏功能障碍在确定是否需要ECMO方面的作用。功能的超声心动图指标包括主动脉和肺动脉峰值流速、主动脉和肺动脉加速度、缩短分数、圆周纤维缩短速度、右心室输出量和左心室输出量。患者接受了分阶段治疗方案,先使用高频振荡通气(HFOV),若HFOV抢救失败则进行ECMO。9名患者病情逐渐恶化,需要ECMO(第1组);12名患者未使用ECMO而康复(第2组)。在肺泡动脉氧分压差、年龄、体重、胎龄、血管活性药物支持、平均气道压、体循环血压或动脉血气参数方面,两组之间无显著差异。第1组的肺动脉和主动脉峰值流速显著更低,肺动脉加速度更低,缩短分数更低,圆周纤维缩短速度更低(P小于0.05)。我们发现,肺动脉峰值速度小于0.70 m/s且肺动脉加速度小于14 m/s²的值可预测第1组9名患者中有7名需要ECMO,第2组12名患者中有11名未使用ECMO而康复(P小于0.01,Fisher精确检验)。我们得出结论,在初始超声心动图评估中,与一组气体交换严重程度相似但未使用ECMO而康复的患者相比,那些随后需要ECMO的患者心脏功能受损。我们推测,对ECMO候选者进行心脏功能的超声心动图评估可能有助于预测随后是否需要ECMO或迅速转至ECMO中心。